Effects of Self-Efficacy-Oriented Art Therapy on Quality of Life in Adolescents and Young Adults Undergoing Medical Rehabilitation

Effects of Self-Efficacy-Oriented Art Therapy on Quality of Life in Adolescents and Young Adults Undergoing Medical Rehabilitation - SELA-AYA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00041084

Enrollment

Registered

2026-07-22

Start date

2026-07-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents and young adults undergoing inpatient medical rehabilitation with or after cancer, cystic fibrosis, congenital or acquired heart diseases

Interventions

Group 1: tandard inpatient medical rehabilitation including participation in the structured self-efficacy-oriented art therapy program. Standardized Patient-Reported Outcome Measures (PROMIS®) assessi

Eligibility

Sex/Gender

All

Age

15 Years to 39 Years

Inclusion criteria

Inclusion criteria: inpatient medical rehabilitation at Nachsorgeklinik Tannheim, diagnosis of cancer, cystic fibrosis, congenital or acquired heart disease, chronic lung disease, inflammatory bowel disease, type 1 diabetes mellitus, or obesity, sufficient German language skills to understand the study information and complete the questionnaires, ability to complete the questionnaires independently, and written informed consent; for minors, additional written informed consent from a parent or legal guardian.

Exclusion criteria

Exclusion criteria: Failure to meet one or more inclusion criteria.

Design outcomes

Primary

Measure	Time frame
Change in health-related quality of life measured by the PROMIS® Global Mental Health 4a score between baseline at the beginning of inpatient rehabilitation (T0) and discharge at the end of rehabilitation (T1). Data are collected using the standardized PROMIS® Global Mental Health 4a patient-reported outcome measure.	—

Secondary

Measure	Time frame
Changes in self-efficacy, anxiety, and depression between baseline (T0) and discharge (T1). Self-efficacy is assessed using the PROMIS® General Self-Efficacy 4a, PROMIS® Self-Efficacy for Managing Emotions 4a, PROMIS® Self-Efficacy for Managing Symptoms 4a, and the General Self-Efficacy Scale (SWE). Anxiety and depression are assessed using the PROMIS® Anxiety 4a and PROMIS® Depression 4a instruments. In addition, the qualitative component explores participants' experiences with art therapy, perceived mechanisms of action, and individual change processes using problem-centered interviews.	—

Measure

Time frame

Changes in self-efficacy, anxiety, and depression between baseline (T0) and discharge (T1). Self-efficacy is assessed using the PROMIS® General Self-Efficacy 4a, PROMIS® Self-Efficacy for Managing Emotions 4a, PROMIS® Self-Efficacy for Managing Symptoms 4a, and the General Self-Efficacy Scale (SWE). Anxiety and depression are assessed using the PROMIS® Anxiety 4a and PROMIS® Depression 4a instruments. In addition, the qualitative component explores participants' experiences with art therapy, perceived mechanisms of action, and individual change processes using problem-centered interviews.

—

Countries

Germany

Contacts

Public ContactMichaela Döring

Nachsorgeklinik Tannheim gGmbH

michaela.doering@tannheim.de+4977059200

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026